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duration on the most recent ECG. 
Results: A total of 1,134 patients were actively enrolled in the program. of which 592 
(52%) had EF ~0.35. Out of this group, 62 (10%) were in atrial fibrillation or flutter and 55 
(9%) had a preexisting pacemaker, which would have excluded them from entry into 
MIRACLE. The table lists the demographlcs and ECG charactenstics of the remaining 
475 patlents who were in sinus rhythm. 
Table. Demographics and EGG characteristics of 475 patients with EF~0.35. 
Age ~65 years 
Z5 years 
Male 
Left bundle block 
Right bundle block 
IVCDt 
QRS <130ms 
rl30ms 
N (%) 
186 (39%) 
289 (61%) 
317 (67%) 
76 (16%) 
32 (7%) 
99(210/o) 
357 (75%) 
118 (25%) 
t QRS ZllOms but neither left nor right bundle block. 
Conclusion: Among 592 patients with symptomatic heart fatlure enrolled in a CHF cars 
management program who have EF $35, 118 (20%) met the ECG entry criteria used in 
the MIRACLE study. 
1090-19 Rapid Detection of Atrial Tachyarrhythmia in Pacemaker 
Patients Using Home Monitoring 
Andreas Hartmann, Christoph Stellbrink, Jas Gill, Massimo Santini, Eckhart Wunderlich, 
Diran Igidbashian, St. Georg Hospital, Leipzig, Germany 
Background: The current standard pacemaker follow-up scheme consists of regular 
clinical examinations every 3 to 6 months This may entail a significant delay for the reac- 
tion to cardiac events, a. g. atrial tachycardia (AT), especially if asymptomatic. Home 
Monitoring (HM) may present a solution, as it offers frequent data transmission from the 
implant to the physlcian. 
Methods: In a European multicenter clinical investlgatlon, patients having indications for 
dual chamber pacing have been implanted wth the pacemaker BA03 DDDR (Biotronik 
Inc.). The BA03 offers HM, i.e. automatically daily transfers a survey on mean ventricular 
rate, prevalence of intrinsic atrial and ventricular rhythm, atrioventricular conduction, and 
ventricular extrasystole via a GSM-net based mobile phone to a HM service center. The 
service center immediately sends the data to the physician via fax as so-called Cardio 
Report showing the latest data and the preceding data in tables and graphs. A patient 
may additionally trigger messages by applying a magnet. Primary endpoint of the study is 
the rellability of HM and will be presented elsewhere. We analyzed the clinical value of 
the transmitted data with respect to diagnosis of AT. 
Results: Hundred twenty two patients have been included. Follow-up with HM lasted 62 
* 23 days (mean * SD). 6425 HM messages are considered for the analysis. For 8 
patients, AT were documented by conventional means (24-h long-term-ECG, symp- 
toms). The onset of these AT could all be directly correlated to coincident changes of 
mean heart rate and atrioventricular synchrony in the HM data. However, similar 
changes were observed for 26 other patients. For 7 of these, the changes in HM param- 
eters could be correlated to other clinically relevant events, like lead dislocation and 
undersensing. Ten of the remaining patients were known to have paroxysmal AT, 
although no event could be documented by conventional means during inclusion. For the 
other 9 patients, the origin IS unclear. 
Conclusion: Home Monitoring offers the possibility for improving follow-up of pace- 
maker patients by reducing reaction time to clinically relevant events. Sensitivity to AT is 
sufficient, however, spectficity has to be Improved. 
1090-20 A Randomized Study of Three Tilt Test Protocols With 
Long-Term Follow-Up by Implantable Loop Recorder 
David J. Farwell, Neil Sulke, Eastbourne General Hospital, Eastbourne, United Kingdom 
Background: Head-Up tilt testing is an important tool in the diagnosis of syncope. We 
prospectively evaluated the clinical impact of three separate protocols. Methods: 214 
patients with recurrent syncope were randomized to one of three tilt protocols, Drug Free, 
GTN and Adenosine, with upright carotid sinus massage. Tilts were terminated at the 
onset of syncope, when systolic BP reached 60 mmHg or in the presence of prolonged 
hypotenslon (>3mins systokc BP&OmmHg). Appropriate empiric therapies were com- 
menced according to the result of the tilt test. 103 Patients were randomized to implant- 
able loop recorder “se &follow up, to cross correlate spontaneous syncopal events to tilt 
result, thus estimating the true sensitivity and specificity of tilt testing. Results were clas- 
sified according to published criteria. Results: 13 patients rewed pacemakers for class I 
indiacations. 
Tilt Test Result 
Negatwe 
Vase-vagal 
CSH 
Aut. Fail. 
Pseudseizure 
POTS 
Intolerant 
Adenosine 
75% 
15% 
10% 
0 
0 
0 
0 
Drug Free 
56% 
21% 
7% 
10% 
1% 
1% 
1% 
GTN All 
24% 52% 
55% 33% 
3% 6% 
2% 4% 
3% 1% 
3% 1% 
5% 2% 
All three protocols gave similar VASIS classification results. We were able to correlate 
spontaneous syncope to tilt result in 34 patients. Sensitivities for all (combined proto- 
cols), adenosine, GTN and drug free protocols were 33%, 33%, 100% and 0% respec- 
tively. Specificities were 64%. loo%, 60%and 71% respectively. Conclusions: A 
diagnosis was made in 47% of patients with syncope “sing tilt testing. The GTN protocol 
gave the most true positw results with the best sensitivity and specificity. 
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803-l The Canadian Registry of Atrial Fibrillation: Lack of 
Prognostic Differences Between Atrial Fibrillation and 
Atrial Flutter 
Paul A. LeLoner, Karin H. Humphries, Andrew Krahn, Stuart Connolly, Mario Talajic, 
Martin Green, Robert Sheldon, Paul Donan, David Newman, Charles R. Kerr, Raymond 
Yee, George J. Klein, Boston Medical Center, Boston, MA, University of Western 
Ontario, London, ON, Canada 
Background: The incidence of stroke is widely believed to be lower in atrial flutter (AFL) 
than in atrial fibrillation (AF) since the former represents an organized atrial rhythm. Con- 
vincing data to support this belief are not available. Methods: Between 1991 and 1996, 
1097 patients were enrolled in Canadian Registry of Atrial Fibrillation (CARAF) from six 
major clinical centers throughout Canada. Of these, 94 patients with atrial flutter (AFL) 
and 767 with atrial fibrillation (AF) met inclusion criteria. Patients were followed annually 
for a median of 6.9 years and 61.7% were male. End-points were compared between 
patients with AFL and AF using Cox proportIonal hazards models for time-to-stroke and 
mortality adjusted for warfarin “se and cardioversions. Results: The stroke rate was 
1.3%/person-year in the AF group and 1.2%/person-year in the AFL group. The death 
rate was 3.5%/person-year in the AF group and 2.9%/person-year in the AFL group. The 
hazard ratio of AFL versus AF for stroke was 0.76 (Cl 0.33 to 1.82) (p=O.56) and for rnor- 
tality 0.71 (Cl 0.42 to 1.20) (p=O.2). Age, history of stroke, diabetes, valvular heart dts- 
ease. congestive heart failure. left ventricular hypertrophy and a hypokinetlc ventricle 
wars associated with increased mortality, regardless of rhythm. The same risk factors, 
with the exceptton of diabetes and congestive heart failure, were associated with stroke, 
regardless of rhythm. The use of wariarin was the same in both groups (p=O.l). Conclu- 
sions: Neither nsk of stroke nor mortality differed between patients with AFL and AF. 
These results suggest the indications for anticoagulation should be the same for patients 
with either rhythm. 
9:30 a.m. 
803-2 Determinants of Improvement of Quality of Life in 
Persistent Atrial Fibrillation: Data From the RACE Study 
Vincent E. Haoens, Adelita V. Ranchor, Eric Van Sonderen, Jan H. Kingma, Hans A. 
Bosker. Otto Kamp, Tsjerk Kingma. Harry J. Crijns. lsabelle C. Van Gelder. for the RACE 
Investigators, University Hospital, Groningen, The Netherlands 
Background: Persistent atrial fibrillation (AF) may cause symptoms like fatigue, and 
dyspnea. This can impair quality of life (QoL). Treatment of AF with either rate or rhythm 
control may influence QoL. We sought to determine indicators of QoL changes during 
long-term follow-up. 
Methods: In 352 patients included in the RACE study (rate versus rhythm control I” per- 
sistent AF), QoL was assessed. Rats control patients (n=175) received negative chrono- 
tropic drugs, and oral anticoagulation (OAC). Rhythm control patients (n=177) underwent 
serial electrocardioversion. antiarrhyihmic drugs, and OAC as needed. QoL was 
assessed “sing the Short Form (SF)-36 health survey questionnaw at baseline and end 
of study (EoS), after2-3 years follow-up. Baseline and follow-up characteristics related to 
QoL Improvement were determined. 
Results Mean aoe is 66 * 9 “ears. oresent AF duration 1 month. 60% had underlwo 
I  
heart disease (49% class I, and 49% class II for heart failure), 70% had complaints ot Ai 
at inclusion. At the EoS, 10% versus 40% in rate versus rhythm control group were in 
sInus rhythm, respectively. Stepwise regression analysis showed that in the total group, 
sinus rhythm at EoS was related to a significant improvement of QoL (physical function- 
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ing, p=O.O07, role limitation due to physical problems, p=O.O47, role limitation due to 
emotional problems, p&036, and vitality, p=O.OOO). but not the type of randomized strat- 
egy. Also patients < 69 years (social functioning, ~~0.03, and pain, p=O.O44), AF duration 
< 1 month (social functioning, p=O.O32), and those with complaints of AF at baseline (role 
limitation due to physical problems, p=O.O41) showed QoL Improvement. 
Conclusion: Maintenance of sinus rhythm rather than the assigned strategy is ah impor- 
tant parameter for improvement of QoL. 
benefit of maintaining SR beyond preventing symptoms. 
9:45 a.m. 
Objective: To test retrospectively the hypothesis that long-term maintenance of SR 
translates in prolonged survival and reduced morbidity. 
Methods: 569 ablated patients (pts) (mean age, 65 * 9 yrs; chronic AF, 21%; mean AF 
duration. 2.9 yrs) were compared with 562 (65 * 10 yrs; chronic AF. 19%; mean AF dura- 
tion, 2.1 yrs) who were given antiarrhythmic drugs for preventing recurrent AF, between 
January 1996 and March 2001. For both groups follow-up, including serial visits, 24-hour 
Halter recordings and echocardiograms, began at hospital discharge, ended in March 
2002, and averaged 664 days. 
Results: At final analysis, 20% of ablated patients and 56% among medically treated 
have had their first relapses (P<O.OOi, by log-rank statistic). Cox proportional hazard 
model revealed ablation was J-fold as efficacious as drugs in preventing recurrences 
(hazard ratio [HR], 0.31, 95%CI 0.22 to 0.47, P=O.O02). When entered as a timedepen- 
dent variable into the Cox model, maintenance of SR, was associated with substantial 
reductions in the risk of death (HR, 0.46, 95%CI 0.22 to 0.66: P<O.OOl) and major mor- 
bidities mainly due to heart failure and stroke (HR, 0.45, 95%CI 0.21 to 0.57; P<O.OOl), 
either considering all patients or the two treatment groups separately (ratio of HRs 0.99, 
PzO.76). 
Conclusion: These results question the conclusions of the AFFIRM trial about the lack 
of benefit of SR control over rate control by drugs in AF pts, and substantiate the claim 
that obtaining SR is more important than using SR as a marker of good health. That SR 
resulted as a strong prognostic deteninant reinforces the concept that, AF, by itself or 
as hastening factor, may cause excess modality and morbidity. Thereby, its prevention 
and suppression should always be pursued. 
803-3 The Detection of Left Atrial Thrombi in Patients With 
Atrial Fibrillation Were Associated With 
Thromboembolic Events During Long-Term Follow-Up 
Karlheinz Seidl, Margit Vater, Monika Rameken, Andreas Brandt, Axel Droegafhueller, 
Jochen Senges, Head Center, Ludwigshafen. Germany 
Aim of the study was evaluate the long-term outcome in patients (pts) with atrial fibrilla- 
tion (AF), in whom a left atrial thrombus was detected by transesophageal echocardio- 
graphy (TEE) in comparison to pts without thrombus. 
Methods: In this single center observational study all pts were enrolled in this analysis if 
they were admitted to our hospital for the first time with the attention to cardioved atrial 
fibrillation in sinus rhythm. 
Results: Overall 447 pts were included in this study and in all pts TEE was performed. In 
42 pts the left atrial thrombus was detected. 34 of these 42 pts (60%) were effectively 
anticoagulated with ah INR (2 - 3). TEE was repeated in 31 of these 42 pts after 4 - 6 
weeks. No left atrial thrombus was found in 20 pts. These 20 pts were then cardioverted. 
In the remaining 11 pts the left atrial thrombus was still present. During follow up of a 
median of 20 months 4 of these 42 pts had ah embolic event (9.5%). All pts with a throm- 
bus had ah effective anticoagulation (INR 2-3) after discharge of the hospital. During the 
same follow up period 12/405 pts without a thrombus had a thromboembolic event 
(2.6%). Of these 405 pts 63% were effectively anticoagulated. Conclusion: Embolic event 
rate in pts with a left atrial thrombus is 9.5% in contrast to only 2.6% in pts without a 
thrombus during a median follow-up time of 20 months. 
lo:oo a.m. 
803-4 An Endovascular Approach to Stroke Prevention in 
Atrial Fibrillation: Results of the Multicenter PLAATO 
(Percutaneous Left Atrial Appendage Transcatheter 
Occlusion) Feasibility Trial 
Mark Reisman, William Gray, Horst Sievert. Paul Kramer, Peter C. Block, Carlo DiMario, 
Antonio L. Badorelli, Paolo Della Bella, Heyder Omran. Athena Poppas, David 0. 
Williams, Allan Skanes, Bernhard Meier, Toshiko Nakai, Michael D. Lesh, Swedish Head 
Institute, Seattle, WA 
Bsckground: Thromboembotism due to atrial fibrillation (AF) is a frequent cause of 
stroke. During non-rheumatic AF, thrombus originates predominantly in the left atrial 
appendage &AA). Anticoagulation (warfarin) therapy has demonstrated a two-thirds 
reduction in stroke risk. In pts suboptimal for wadarin therapy, occlusion of the LAA may 
significantly reduce the risk of thromboembolism. The purpose of this phase one study is 
to determine the safety and feasibility of the PLAATOTM procedure in high risk AF pts 
who are poor warfarin candidates. 
Methods: Patients were enrolled who have chronic or paroxysmal AF and are at high 
risk for stroke based oh the presence of congestive heart failure, diabetes mellitus, 
hypertension, history of Stroke/transient ischemic attack (TIA), or high-risk echo findings 
with transesophageal echocardiography (TEE). Patients with existing LAA thrombus 
ware excluded. The PLAATO system consists of a self-expanding cage covered with 
ePTFE delivered through a 12Fr transseptal sheath specially designed to access the 
LAA. Device placement is guided by fluoroscopy and TEE. 
Results: A total of 56 pts, age 7Oi7 yrs (M/F=36/20) were enrolled. Device deployment 
was successful in 55156 pts (96%). One pt had a groin complication during venous 
access so the procedure was aboded. Seventeen of 56 pts had a history of Stroke/IA 
and 26156 pts had high risk echo findings defined as low LAA emptying velocity or spon- 
taneous echo contrast in the LAA. Devices were oversized by 20%.50% of LAA diame- 
ter. Procedure time was 76*30 min. Procedural complication occurred in 6 pts (10%) and 
included 3 pedcardial effusion, 2 groin hematoma and 1 false aneurysm. Clinical follow- 
up at 6 mos (33 pts) included 1 death (not device related) and 0 CVA’s. TEE follow-up at 
6 mos (16 pts) confirmed stable implant position with a smooth atrial-facing SurfaCe. In 
one pt, a smooth echodense layer was seen along device surface at 1 and 6 mos, which 
resolved at 9 mos: ho clinical events have occurred in this pt. 
Conclusions: Transcatheter occlusion of the LAA with a novel implantable device 
appears feasible and safe. Whether or not it confers protection against stroke will be 
predicated from our long term clinical follow-up. 
10:15 a.m. 
803-5 Sinus Rhythm Control in Atrial Fibrillation: Outcomes 
From a Controlled Long-Term Ablation Study 
Carlo Pawone, Salvatore Rosanio, Giuseppe Augello, Alessia Pappone, Patrizio 
Mazzone, Simone Gullena, Mario Pittalis, Gabriele Pagfino, Gabriele Vicedomini. San 
Raffaele University Hospital, Milan, Italy 
Background: Atrial fibrillation (AF) is associated with a 1.5- to 1.9-fold modality risk and 
2.6-to 4.5-fold risk of stroke as compared with subjects in sinus rhythm (SR). Circumfer- 
ential pulmonary vein ablation (CPVA) has emerged as safe and effective treatment for 
curing atrial fibrillation (AF). However only limited evidence exists to support a clinical 
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814-l Lack of OT Prolongation With Amiodarone Increases 
Arrhythmic Risk 
Peter Smetana, Esther Pueyo, Katerina Hnatkova. Marek Malik, St. George’s Hospital 
Medical School, London, United Kingdom 
Background:The superior anti-arrhythmic efficacy of amiodarone (A) is padly explained 
by ah almost heart rate independent prolongation of the QT inteival. Thus A treated 
patients with reduced QT prolongation might be at higher arrhythmic risk. We therefore 
investigated QT intervals at different heart rates in A and placebo (P) treated post-myo- 
cardial infarction (Ml) patients. Methods: In 24-hours recordings from 666 EMIAT 
patients (462 A, 404 P) obtained 1 month after randomisation, QT intervals were 
obtained automatically by using the Pathfinder software (Reynolds Med Tee). QT values 
were averaged over 10.ms RR interval bins from 550 to 1150 ms in each recording. 
Results were compared between survivors (SUR, circles) and victims of non-arrhythmic 
(NAD. dots) and arrhythmic death (AD, triangles) both in A (left panel) and P (right panel) 
groups. Results: As expected QT intervals were significantly longer at all investigated 
RR interval bins oh A. However, whereas there was ho significant difference in the QT 
intervals between SUR, NAD and AD patients in the P arm (SUR vs AD at 540-550 ms: 
336+ 25 vs 337i 23 ms, p=ns and at 1140-l 150 ms: 426+ 40 vs 417~ 46 ms, p=ns), QT 
intervals in the A arm were shorter in AD patients than in SUR at all RR interval bins 
(SUR vs AD at 540-550 ms: 349+ 24 vs 346+ 20 tns, p=ns and at 1140-l 150 ms: 469i 
40 “s 423+ 20 ms, p=2x 1 Od) 
Conclusions: Reduced prolongation of QT interval by A increases the risk of AD in post- 
Ml patients. 
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